...
首页> 外文期刊>Cells >Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
【24h】

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease

机译:淀粉样蛋白β和磷酸化Tau诱导阿尔茨海默病患者的缺陷自噬和水肿

获取原文
           

摘要

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by memory loss and multiple cognitive impairments. Several decades of intense research have revealed that multiple cellular changes are implicated in the development and progression of AD, including mitochondrial damage, synaptic dysfunction, amyloid beta (Aβ) formation and accumulation, hyperphosphorylated tau (P-Tau) formation and accumulation, deregulated microRNAs, synaptic damage, and neuronal loss in patients with AD. Among these, mitochondrial dysfunction and synaptic damage are early events in the disease process. Recent research also revealed that Aβ and P-Tau-induced defective autophagy and mitophagy are prominent events in AD pathogenesis. Age-dependent increased levels of Aβ and P-Tau reduced levels of several autophagy and mitophagy proteins. In addition, abnormal interactions between (1) Aβ and mitochondrial fission protein Drp1; (2) P-Tau and Drp1; and (3) Aβ and PINK1/parkin lead to an inability to clear damaged mitochondria and other cellular debris from neurons. These events occur selectively in affected AD neurons. The purpose of our article is to highlight recent developments of a Aβ and P-Tau-induced defective autophagy and mitophagy in AD. This article also summarizes several aspects of mitochondrial dysfunction, including abnormal mitochondrial dynamics (increased fission and reduced fusion), defective mitochondrial biogenesis, reduced ATP, increased free radicals and lipid peroxidation, and decreased cytochrome c oxidase (COX) activity and calcium dyshomeostasis in AD pathogenesis. Our article also discusses how reduced levels of Drp1, Aβ, and P-Tau can enhance the clearance of damaged mitochondria and other cellular debris by autophagy and mitophagy mechanisms.
机译:阿尔茨海默病(AD)是一种渐进神经退行性疾病,其特征是记忆丧失和多重认知障碍。几十年的激烈研究表明,多种细胞变化均涉及广告的开发和进展,包括线粒体损伤,突触功能障碍,淀粉样蛋白β(Aβ)形成和积累,高磷酸化Tau(P-Tau)形成和积累,解毒的MicroRNA广告患者的突触损伤和神经元损失。其中,线粒体功能障碍和突触损伤是疾病过程中的早期事件。最近的研究还揭示了Aβ和P-Tau诱导的缺陷的自噬和乳化物是AD发病机制中的突出事件。年龄依赖性增加的Aβ和P-TAU水平降低了几种自噬和蛋白质的水平。此外,(1)Aβ和线粒体裂变蛋白DRP1之间的异常相互作用; (2)P-TAU和DRP1; (3)Aβ和PINK1 / Parkin导致无法清除神经元的受损线粒体和其他细胞碎片。这些事件在受影响的广告神经元中选择性地发生。我们的文章的目的是突出Aβ和P-Tau诱导的近期发育缺陷的自噬和水肿。本文还总结了线粒体功能障碍的几个方面,包括线粒体动态(增加裂变和降低融合增加),有缺陷的线粒体生物发生,降低的ATP,增加的自由基和脂质过氧化,以及广告中的细胞色素C氧化酶(COX)活性和钙软化钙脱钙酶发病。我们的文章还讨论了DRP1,Aβ和P-Tau水平降低的程度如何通过自噬和水道机制来增强受损线粒体和其他细胞碎片的清除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号